Carregant...

Effect of Pioglitazone and Ramipril on Biomarkers of Low-Grade Inflammation and Vascular Function in Nondiabetic Patients with Increased Cardiovascular Risk and an Activated Inflammation: Results from the PIOace Study

AIMS: This study investigated the effects of pioglitazone (PIO), ramipril (RAM), or their combination (PIRA) on low-grade inflammation in nondiabetic hypertensive patients with increased cardiovascular risk. METHODS AND RESULTS: Patients enrolled in this placebo-controlled, double-blind, randomized,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pfützner, Andreas, Hanefeld, Markolf, Dekordi, Lida A, Müller, Jürgen, Kleine, Iris, Fuchs, Winfried, Forst, Thomas
Format: Artigo
Idioma:Inglês
Publicat: Diabetes Technology Society 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3192606/
https://ncbi.nlm.nih.gov/pubmed/21880242
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!